Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm

AIDS

Volumn 12, Issue 17, 1998, Pages 2261-2270

  Nilsson, Charlotta ^a   Mäkitalo, Barbro ^a   Thorstensson, Rigmor ^a   Norley, Stephen ^b   Binninger Schinzel, Doris ^b   Cranage, Martin ^c   Rud, Erling ^d   Biberfeld, Gunnel ^a   Putkonen, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PAUL EHRLICH INSTITUT   (Germany)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Animal model; HIV 2; Live attenuated vaccine; Mucosal transmission; SIV

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS DNA; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 2; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MACACA; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS ATTENUATION; VIRUS IMMUNITY;

EID: 0032481040     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199817000-00006     Document Type: Article

References (38)

1. Lamb-Wharton RJ, Joag SV, Stephens EB, Narayan O: Primate models for AIDS vaccine development. AIDS 1997, 11 (suppl A):S121-S126.
2. Novembre FJ, Saucier M, Anderson DC, et al.: Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 1997, 71:4086-4091.
3. Johnson BK, Stone GA, Godec MS, et al.: Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res Hum Retroviruses 1993, 9:375-378.
4. Putkonen P, Böttiger B, Warstedt K, et al.: Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. J Acquir Immune Defic Syndr 1989, 2:366-373.
5. Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J: Infection of cynomolgus monkeys with a chimeric HIV-1/SIV virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 1992, 5:639-646.
6. Putkonen P, Kaaya LL, Böttiger D, et al.: Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus. AIDS 1992, 6:257-263.
7. Putkonen P, Thorstensson R, Albert J, et al.: Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 1990, 4:783-789.
8. Marthas MI, Sutjipto S, Higgins J, et al.: Immunization with a live attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol 1990, 64:3694-3700.
9. Daniel MD, Kirchhoff F, Czajak SC, et al.: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258:1938-1941.
10. Rud EW, Cranage M, Yon J, et al.: Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol 1994, 75:529-543.
11. Almond N, Kent K, Cranage M, et al.: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995, 345:1342-1344.
12. Norley S, Beer B, Binniger-Schinzel D, et al.: Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 1996, 219:195-205.
13. Stahl-Hennig C, Dittmer U, Nisslein I, et al.: Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol 1996, 77:2969-2981.
14. Cranage MP, Whatmore AM, Sharpe SA, et al.: Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 1997, 229:143-154.
15. Miller CJ, McChesney MB, Lü X, et al.: Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. Virol 1997, 71:1911-1921.
16. Whatmore AM, Cook N, Hall GA, et al.: Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol 1995, 69:5117-5123.
17. Sharpe SA, Whatmore AM, Hall GA, Cranage MP: Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulent-revertant virus. J Gen Virol 1997, 78:1923-1927.
18. Wyand MS, Manson KH, Garcia-Moll M, et al.: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996, 70:3724-3733.
19. Baba IW, Jeong YS, Penninck D, et al.: Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 1995, 267:1820-1825.
20. Wyand MS, Manson KH, Lackner AA, Desrosiers RC: Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Natl Med 1997, 3:32-36.
21. Liska V, Lerche NW, Ruprecht RM: Simultaneous detection of simian retrovirus type D serotypes 1, 2, and 3 by polymerase chain reaction. AIDS Res Hum Retroviruses 1997, 13:433-437.
22. Fultz PN, McClure HM, Anderson DC, et al.: Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercorebus atys). Proc Natl Acad Sci USA 1986, 83:5286-5290.
23. Quesada-Rolander M, Mäkitalo B, Thorstensson R, et al.: Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses 1996, 12:993-999.
24. Putkonen P, Thorstensson R, Walther L, et al.: Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses 1991, 7:271-277.
25. SBI-6669 and HTLV-IV (SIVmac). AIDS 1988, 2:195-199.
26. Nilsson C, Thorstensson R, Gilljam G, et al.: Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Res 1995, 4:165-175.
27. Finney DJ: Statistical Method in Biological Assay. London: Charles Griffin and Company Ltd; 1978.
28. Andersson S, Mäkitalo B, Thorstensson R, et al.: Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J Infect Dis 1996, 174:977-985.
29. Rose J, Silvera P, Flanagan B, Kitchin P, Almond N: The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J Virol Methods 1995, 51:229-240.
30. Walther L, Grankvist O, Putkonen P, Biberfeld G, Thorstensson R: Nested polymerase chain reaction primers that distinguish between SIVsm and HIV type 2. AIDS Res Hum Retroviruses 1996, 12:1077-1079.
31. Titti F, Sernicola I, Geraci A, et al.: Live attenuated simian immunodeficiency virus prevents superinfection by cloned SIVmac251 in cynomolgus monkeys. J Gen Virol 1997, 78:2529-2539.
32. Putkonen P, Walther L, Zhang Y-J, et al.: Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat Med 1995, 1:914-918.
33. Clements JE, Montelaro RC, Zink MC, et al.: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 1995, 69:2737-2744.
34. Cole KS, Rowles JL, Jagerski BA, et al.: Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997, 71:5069-5079.
35. Xu X-N, Screaton GR, Gotch FM, et al.: Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 1997, 186:7-16.
36. Johnson RP, Glickman RL, Yang JQ, et al.: Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 1997, 71:7711-7718.
37. Levy JA, Mackewicz CE, Barker E: Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996, 17:217-224.
38. Cocchi F, DeVico AL, Garzino-Demo A, et al.: Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.